Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 873, pseudogene (RNU6-873P) is a human genomic sequence classified as a **pseudogene** of the U6 small nuclear RNA gene family[1]. U6 snRNA is an essential component of spliceosomal machinery, participating in pre-mRNA splicing in the nucleus; however, **RNU6-873P** is not believed to produce a functional RNA product or have a known role in the spliceosome[1][5][3]. Pseudogenes such as RNU6-873P usually arise from gene duplication or retrotransposition and subsequently lose their protein-coding or functional RNA capability[4]. While some pseudogenes can regulate gene expression by acting as competitive endogenous RNAs (ceRNAs) or miRNA sponges[4], there is currently **no evidence** indicating RNU6-873P has such regulatory activity, nor any disease association or therapeutic targeting relevance[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 873, pseudogene (RNU6-873P).